microbiology testing services

Similar documents
Concise Antibiogram Toolkit Background

BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016)

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

2015 Antibiotic Susceptibility Report

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

2016 Antibiotic Susceptibility Report

C&W Three-Year Cumulative Antibiogram January 2013 December 2015

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

Antimicrobial Susceptibility Testing: Advanced Course

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

4 th and 5 th generation cephalosporins. Naderi HR Associate professor of Infectious Diseases

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER

2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital

QUICK REFERENCE. Pseudomonas aeruginosa. (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.)

CONTAGIOUS COMMENTS Department of Epidemiology

2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital

CONTAGIOUS COMMENTS Department of Epidemiology

CUMULATIVE ANTIBIOGRAM

RCH antibiotic susceptibility data

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.

Antibiotic Stewardship Program (ASP) CHRISTUS SETX

BactiReg3 Event Notes Module Page(s) 4-9 (TUL) Page 1 of 21

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS

Antimicrobial susceptibility

Standing Orders for the Treatment of Outpatient Peritonitis

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

EUCAST recommended strains for internal quality control

Recommendations Regarding Use of Rapid Blood Pathogen Identification Panel Data

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Antimicrobial Susceptibility Patterns

TABLE OF CONTENTS. Urine - Gram Positive Susceptibility Reporting 1 Staphylococcus species, MRSA...11

A Multi-Laboratory Study of the BIOMIC Automated Well Reading Instrument versus

Mark Your Calendars Now! Next Event Ships: September 14, 2015

Standing Orders for the Treatment of Outpatient Peritonitis

The Cost of Antibiotic Resistance: What Every Healthcare Executive Should Know

Intrinsic, implied and default resistance

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

Leveraging the Lab and Microbiology Department to Optimize Stewardship

CONTAGIOUS COMMENTS Department of Epidemiology

2015 Antimicrobial Susceptibility Report

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Antimicrobial Resistance Advisory Workgroup (ARAW) Members

Antimicrobial Susceptibility Summary 2011

Understanding the Hospital Antibiogram

European Committee on Antimicrobial Susceptibility Testing

SHC Clinical Pathway: HAP/VAP Flowchart

York Chairman David B. Jones, MD

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

European Committee on Antimicrobial Susceptibility Testing

Policy # MI_AST Department of Microbiology. Page Quality Manual

Antimicrobial Susceptibility Summary 2012

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

Guidelines for Laboratory Verification of Performance of the FilmArray BCID System

Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India

High Antibiotic Resistance Pattern Observed in Bacterial Isolates from a Tertiary Hospital in South East Nigeria

Antimicrobial Stewardship Strategy: Antibiograms

Appropriate antimicrobial therapy in HAP: What does this mean?

What s new in EUCAST methods?

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

Antimicrobial Susceptibility Testing: The Basics

Solution Title: Antibiotic Stewardship: A Journey Toward the Triple Aim

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

HOSPITAL-ACQUIRED INFECTIONS AND QASM PATIENTS

Canadian Nosocomial Infection Surveillance Program 2018 SURVEILLANCE FOR HEALTHCARE ACQUIRED CEREBROSPINAL FLUID SHUNT ASSOCIATED INFECTIONS

Non-Susceptibility of Bacterial Pathogens Causing Hospital-Onset Pneumonia UK and Ireland,

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

ANTIMICROBIAL RESISTANCE SURVEILLANCE FROM SENTINEL PUBLIC HOSPITALS, SOUTH AFRICA, 2014

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی

Evaluation of the BIOGRAM Antimicrobial Susceptibility Test System

UNDERSTANDING THE ANTIBIOGRAM

4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES

Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges

2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)

Michael Hombach*, Guido V. Bloemberg and Erik C. Böttger

UNDERSTANDING YOUR DATA: THE ANTIBIOGRAM

ADC 2016 Report on Bacterial Resistance in Cultures from SEHOS and General Practitioners in Curaçao

In Vitro Antimicrobial Activity of CP-99,219, a Novel Azabicyclo-Naphthyridone

Principles of Infectious Disease. Dr. Ezra Levy CSUHS PA Program

Hospital-acquired pneumonia (HAP) is the second

5/4/2018. Multidrug Resistant Organisms (MDROs) Objectives. Outline. Define a multi-drug resistant organism (MDRO)

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Antibacterial Resistance In Wales

SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* ...

Detection of ESBL Producing Gram Negative Uropathogens and their Antibiotic Resistance Pattern from a Tertiary Care Centre, Bengaluru, India

Mongolia September 2012

Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune

Antimicrobial Resistance Surveillance from sentinel public hospitals, South Africa, 2013

Int.J.Curr.Microbiol.App.Sci (2017) 6(3):

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

CF WELL Pharmacology: Microbiology & Antibiotics

17June2017. Parampal Deol, Ph.D, MBA Senior Director, R&D Microbiology North America

EARS Net Report, Quarter

Monitoring of AMR in Russia

HPN HOSPITALIZED PNEUMONIA APPLICATION

Preserve the Power of Antibiotics

Antimicrobial resistance surveillance in the South African public sector

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

Transcription:

microbiology testing services

You already know Spectra Laboratories for a wide array of dialysis-related testing services. Now get to know us for your microbiology needs. As the leading provider of renal-specific testing services, we understand the special needs of your dialysis patients. We routinely deliver comprehensive microbiology culture handling, analyses, and reporting with the consistency and accuracy you expect. spectra microbiology Timely, accurate results seven days a week. Experience You Can Depend On Our Clinical Laboratory Scientists have years of clinical microbiology experience, training, and knowledgeensuring expert handling of your cultures. Our Microbiology Managers and Medical Directors have decades of clinical experience should you need to discuss specific needs, results, or interpretations.

Helping You Improve Patient Outcomes Spectra Laboratories has been at the forefront of the renal industry for over 35 years. Our programs enhance the treatment and outcomes of your dialysis patients, and continue to set new standards in quality and service: State-of-the-Art Analysis Methods As bacteria become resistant to more antibiotics, physicians need to know what kind of microbe is present and which antibiotic will be most effective. That s why Spectra Laboratories uses the advanced bacterial identification and susceptibility technology in the Vitek 2 XL Automated System. The technology uses preformed enzymes to rapidly identify organisms. With the Vitek system s extensive knowledge base of phenotypes, identification and susceptibilities are typically achieved within 6-8 hours from set-up time. Using the BacT/ALERT 3D Microbial Detection System, Spectra Laboratories can incubate, agitate, and continuously monitor aerobic and anaerobic media inoculated with blood, PD Fluid Cultures, and Body Fluid Cultures from patients suspected of having bacteremia/fungemia or fluid infection. This means positive cultures can be detected in as little as two hours from the time of incubation in the instrument. Reproducible Reports Standardized protocols and instrumentation Data-Driven Interpretation Guidelines Advanced Expert System for susceptibility reporting Antibiograms Rapid, Comprehensive Reporting Web-based microbiology results Critical microbiology results faxed every 2-6 hours Immediate, direct notification of positive growth results Sunday Notification Program Education and Support Instructions on proper specimen collection and handling Dedicated shipping boxes and collection kits for microbiology specimens Ongoing support from our team of Nephrology Clinical Educators

Antibiogram Reports Because Spectra Laboratories is focused on the renal industry, we can provide unique and valuable data to assist you in managing your clinical operation. As a complement to individual patient reports, we offer an Annual Antibiogram Report, which is derived from a microbiology database of all dialysis patient results. The report is available in three user-friendly formats: 1. Comprehensive 2. PD Fluid 3. Catheter Exit Site Spectra Laboratories Antibiogram 1/1/12-12/31/12 Percentage of susceptible organisms Isolated Organism GRAM NEGATIVE Antibiotic # of Isolates Amikacin Ampicillin Ampicillin/Sulbactam Aztreonam Cefazolin Cefepime Cefotaxime Cefotetan Ceftazidime Ceftriaxone Ciprofloxacin Clindamycin Ertapenem Erythromycin Gentamicin Imipenem Levofloxacin Linezolid Meropenem Moxifloxacin Oxacillin Penicillin Piperacillin/Tazobactam Quinupristin/Dalfopristin Rifampin Tetracycline Ticarcillin/Clavulanic Acid Tigecycline Tobramycin Trimethoprim/Sulfa Vancomycin Achromobacter xylosoxidans 60 20 9 51 0 4 28 7 92 7 11 50 96 71 11 97 Acinetobacter baumannii 558 86 0 91 5 0 81 1 72 10 87 83 91 92 86 Acinetobacter lwoffi 100 98 64 97 31 10 98 41 87 60 98 95 100 97 87 Acinetobacter species 109 98 52 99 32 9 91 29 83 56 98 98 98 95 96 Acinetobacter ursingii 45 97 97 81 53 31 100 100 100 Aeromonas hydrophila 33 100 3 3 100 12 96 100 96 96 100 93 90 100 100 88 Citrobacter braakii 38 100 86 0 100 0 78 78 100 100 100 100 100 100 100 Citrobacter freundii 191 100 87 0 100 0 86 86 100 90 91 100 91 95 87 Citrobacter koseri 229 99 99 95 100 99 98 99 100 97 96 100 100 98 96 Citrobacter species 42 100 90 4 100 52 92 90 100 100 100 100 92 100 100 Enterobacter aerogenes 279 100 93 0 100 1 92 92 100 97 98 99 98 97 95 Enterobacter asburiae 53 100 18 48 94 5 100 91 94 94 96 98 98 100 100 94 Enterobacter cloacae 1228 99 95 1 99 3 95 95 98 98 96 99 97 96 92 Enterobacter species 47 100 93 4 97 91 100 97 97 100 97 95 100 100 97 Escherichia coli 2634 99 38 53 88 81 89 98 87 87 99 82 57 99 99 83 65 Klebsiella oxytoca 314 100 0 86 95 84 96 99 95 96 99 97 98 99 98 97 96 Klebsiella pneumoniae 1551 96 0 82 88 85 88 95 87 87 96 91 89 96 93 88 85 Morganella morganii 250 100 0 0 96 0 99 96 88 96 100 77 72 100 91 64 Pantoea agglomerans 130 100 94 81 100 95 95 96 97 99 99 100 100 100 100 Proteus mirabilis 1075 99 70 79 90 82 90 98 89 89 98 87 67 97 90 74 Proteus vulgaris 39 100 12 74 97 12 100 100 100 84 100 100 100 97 100 95 Providencia stuartii 78 100 2 2 97 1 97 100 93 97 100 2 29 97 2 71 Pseudomonas aeruginosa 1759 97 0 0 0 94 0 93 0 89 80 96 96 0 Pseudomonas luteola 39 97 47 84 5 97 89 97 92 97 100 97 100 94 Pseudomonas putida 88 98 2 4 0 100 6 92 13 98 87 89 100 11 Pseudomonas species 38 97 89 84 74 94 89 97 Pseudomonas stutzeri 38 100 52 94 15 100 100 100 94 100 97 100 95 94 Raoultella planticola 32 100 0 90 96 93 100 100 93 100 100 93 100 100 96 96 100 Serratia marcescens 851 99 97 0 99 99 97 96 99 97 94 99 94 90 97 Sphingomonas paucimobilis 69 86 72 90 20 52 80 41 69 81 91 86 96 97 74 93 Stenotrophomonas maltophilia 226 87 100 76 98 GRAM POSITIVE Beta-hemolytic Streptococcus 46 76 84 78 79 68 100 100 100 Coagulase Negative Staphylococcus 9579 41 56 31 75 43 99 63 30 4 99 96 83 100 57 100 Corynebacterium species 125 13 90 53 99 Corynebacterium striatum 98 14 90 33 97 Enterococcus casseliflavus 42 95 88 26 80 100 92 7 96 100 7 Enterococcus faecalis 2371 94 68 14 69 99 93 0 22 99 93 Enterococcus faecium 354 15 10 5 12 99 13 95 20 99 31 Enterococcus gallinarum 39 94 91 67 94 97 89 5 67 100 5 Enterococcus species 272 78 45 22 65 96 76 57 19 100 72 Staphylococcus aureus 13467 57 71 41 96 60 99 71 54 4 99 98 94 99 96 100 Staphylococcus lugdunensis 423 96 75 76 98 97 100 98 82 19 100 99 92 100 95 100 Streptococcus agalactiae 343 100 99 45 96 100 100 99 16 100 100 Streptococcus pneumoniae 41 94 100 100 74 97 83 100 100 86 48 100 Viridans Streptococcus Group 462 83 78 76 87 43 86 45 60 100 Percentage of isolates SUSCEPTIBLE to antibiotic indicated; Based on Clinical and Laboratory Standards Institute (CLSI) guidelines; Blank spaces indicate data not reported.

The Life of a Blood Culture at Spectra Laboratories 1➊ ➊ Upon receipt, blood culture bottles are visually inspected to detect microbial growth. 2➋ ➋ If visual inspection is negative, bottles are incubated in our automated, continuous monitoring BacT/ALERT System for up to five days. If the culture is negative throughout the five day incubation period, a negative report will be issued at 2 hours, 24 hours and on each subsequent day. 3➌ ➌ If the bottles are visually positive upon receipt, or flagged as positive by the BacT/ALERT System anytime during the incubation period, a gram stain is performed for preliminary classification of microorganisms. Bottles are then subcultured on agar media for growth. 4➍ ➍ A Clinical Laboratory Scientist compares the gram stain results to the organism growing on the plated agar media and proceeds with setting up identification and susceptibilities. Identification and susceptibilities are typically achieved within 6-8 hours from set-up time. 5➎ ➎ The Clinical Laboratory Scientist reports all of the identifications and susceptibilities completed by the Vitek System. The majority of identifications and susceptibilities will be reported within 24 hours from the day growth is detected on plated media unless there are unusual or slow growing organisms.

Microbiology Testing Services Anaerobic culture Blood culture Body fluid culture Catheter exit site culture Catheter tip culture Ear/eye culture Environmental - Total Viable Microbial Count (water, bicarbonate, dialysate) - Endotoxin (water, bicarbonate, dialysate) Fungal culture Genital culture Gram stains KOH prep MRSA/VRE screen Nasopharyngeal/throat culture Peritoneal fluid - PD fluid, effluent - Gram stain - Cell count Sputum culture Stools - Clostridium difficile culture and toxin assays - Routine culture - WBC (fecal leukocytes) - Occult blood - Ova and parasite Wound culture Urine - Culture - Routine urinalysis Antibiotic susceptibility performed on pathogens based on standards as defined by CLSI Licensed by multiple states, including the New York State Department of Health and the California State Department of Health, our facilities are CLIA (Clinical Laboratory Improvement Act) certified and accredited by the College of American Pathologists (CAP), and the American Association for Laboratory Accreditation (ISO 15189). Our microbiology laboratories are also certified and uphold the strict standards set forth by the National Environmental Laboratory Accreditation Conference (NELAC), Association for the Advancement of Medical Instrumentation (AAMI), as well as the New York State ELAP (Environmental Laboratory Approval Program). Spectra Laboratories, Inc. 525 Sycamore Drive Milpitas, CA 95035 800-433-3773 8 King Road Rockleigh, NJ 07647 800-522-4662 www.spectra-labs.com 2013, 2018 Fresenius Medical Care, All Rights Reserved. Spectra and the Spectra logo are trademarks of Fresenius Medical Care Holdings, Inc. or its affiliated companies. All other trademarks are the property of their respective owners. MCBTESTSBR Rev. 3/18